Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults. A placebo-controlled trial.

Soares CN, Musolino NR, Cunha Neto M, Caires MA, Rosenthal MC, Camargo CP, Bronstein MD.

Arq Neuropsiquiatr. 1999 Jun;57(2A):182-9.

PMID:
10412515
2.

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA.

Clin Endocrinol (Oxf). 1997 Oct;47(4):439-46.

PMID:
9404442
3.

Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.

Rodríguez-Arnao J, Jabbar A, Fulcher K, Besser GM, Ross RJ.

Clin Endocrinol (Oxf). 1999 Jul;51(1):53-60.

PMID:
10468965
4.
5.

Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study.

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2006 Apr;16(2):132-42.

PMID:
16702006
6.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001.

PMID:
18282776
7.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
8.

Impact of recombinant human growth hormone treatment on psychological profiles in hypopituitary patients with adult-onset growth hormone deficiency.

Giusti M, Meineri I, Malagamba D, Cuttica CM, Fattacciu G, Menichini U, Rasore E, Giordano G.

Eur J Clin Invest. 1998 Jan;28(1):13-9.

PMID:
9502182
9.

The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.

Oertel H, Schneider HJ, Stalla GK, Holsboer F, Zihl J.

Psychoneuroendocrinology. 2004 Aug;29(7):839-50.

PMID:
15177699
10.

Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency.

McMillan CV, Bradley C, Gibney J, Healy ML, Russell-Jones DL, Sönksen PH.

Clin Endocrinol (Oxf). 2003 Oct;59(4):467-75.

PMID:
14510909
11.

Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.

Hansen TB, Gram J, Jensen PB, Kristiansen JH, Ekelund B, Christiansen JS, Pedersen FB.

Clin Nephrol. 2000 Feb;53(2):99-107.

PMID:
10711411
12.
13.

Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.

Fisker S, Vahl N, Hansen TB, Jørgensen JO, Hagen C, Orskov H, Christiansen JS.

Growth Horm IGF Res. 1998 Apr;8(2):105-12.

PMID:
10987677
14.

Effect of growth hormone treatment on trunk fat accumulation in adult GH-deficient Japanese patients: a randomised, placebo-controlled trial.

Chihara K, Kato Y, Takano K, Shimatsu A, Kohno H, Tanaka T, Irie M.

Curr Med Res Opin. 2006 Oct;22(10):1973-9.

PMID:
17022857
15.

A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.

Davies JS, Obuobie K, Smith J, Rees DA, Furlong A, Davies N, Evans LM, Scanlon MF.

Clin Endocrinol (Oxf). 2000 Mar;52(3):295-303.

PMID:
10718827
16.

Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.

Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.

Clin Nephrol. 1999 Aug;52(2):103-9.

PMID:
10480221
17.

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency.

Svensson J, Monson JP, Vetter T, Hansen TK, Savine R, Kann P, Bex M, Reincke M, Hagen C, Beckers A, Ilondo MM, Zdravkovic M, Bengtsson BA, Korbonits M; NN703 Clinical Research Group..

Clin Endocrinol (Oxf). 2003 May;58(5):572-80.

PMID:
12699438
18.

Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.

Li Voon Chong JS, Benbow S, Foy P, Wallymahmed ME, Wile D, MacFarlane IA.

Clin Endocrinol (Oxf). 2000 Nov;53(5):551-9.

PMID:
11106915
19.

Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.

Höybye C, Thorén M, Böhm B.

J Intellect Disabil Res. 2005 Apr;49(Pt 4):245-52.

PMID:
15816811
20.

Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.

Christ ER, Cummings MH, Lumb PJ, Crook MA, Sönksen PH, Russell-Jones DL.

Clin Endocrinol (Oxf). 1999 Aug;51(2):173-9.

PMID:
10468987
Items per page

Supplemental Content

Support Center